Earth Science Tech, Inc. has officially launched its MyOnlineConsultation.com platform through MOCTeledoc LLC, marking a significant expansion of the company's vertically integrated healthcare ecosystem. The platform emerged from a successful beta phase that achieved cash-flow-positive status, positioning it as a new revenue stream alongside divisions that generated $25.9 million for the nine months ended December 31, 2025.
The MOCTeledoc platform provides a fully integrated doctor network that offers technology and clinical staffing solutions to digital health companies. This strategic move connects Earth Science Tech's prescriber network with its compounding pharmacy operations, including RxCompound and Mister Meds, creating a seamless healthcare delivery system. The platform offers turnkey telehealth technology, clinical staffing, and integrated fulfillment services, addressing multiple aspects of digital healthcare delivery in a single solution.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector through wholly-owned subsidiaries. The company's current portfolio includes high-quality compounding pharmacies, telemedicine platforms, and targeted healthcare facilities. RxCompoundStore.com and Mister Meds serve as licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states, supported by Peaks Curative, DOConsultation.com, and Las Villas Health Care for personalized care and clinical support.
Beyond healthcare operations, Earth Science Tech manages Avenvi for real estate and asset management, and MagneChef as a direct-to-consumer brand leveraging proprietary intellectual property for innovative kitchen products. The company also maintains social responsibility initiatives through the Earth Science Foundation, a non-profit dedicated to assisting patients with prescription costs.
The launch represents Earth Science Tech's strategic positioning in the rapidly evolving telehealth market, where integrated solutions are increasingly valued by both providers and patients. By connecting prescribers directly with compounding pharmacies through digital platforms, the company addresses key challenges in medication access and healthcare delivery efficiency. The cash-flow-positive status achieved during beta testing suggests market validation and operational viability for the platform.
For business leaders and technology executives, Earth Science Tech's expansion demonstrates how traditional healthcare companies are leveraging technology to create vertically integrated ecosystems. The model combines multiple revenue streams while potentially improving patient outcomes through coordinated care. The company's approach to integrating telehealth with specialized pharmacy services represents a growing trend in healthcare innovation, where digital platforms bridge gaps between different healthcare service providers.
The latest news and updates relating to Earth Science Tech are available in the company's newsroom at https://ibn.fm/ETST. The full press release announcing the platform launch can be viewed at https://ibn.fm/Pang9. BioMedWire, which distributed the announcement, operates as a specialized communications platform focusing on biotechnology, biomedical sciences, and life sciences sectors, providing corporate communications solutions through its network within the Dynamic Brand Portfolio at IBN.
